AMPHETAMINE

AMPHETAMINE was reported 41905 times

AMPHETAMINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AORTO-CARDIAC FISTULA 6 0.4615
1 GASTRIC ISCHAEMIA 11 0.2245
2 BRACHIAL ARTERY ENTRAPMENT SYNDROME 5 0.1316
3 GASTRIC PNEUMATOSIS 8 0.1127
4 SPINAL SHOCK 8 0.1096
5 PERCEPTUAL DISTURBANCE 4 0.0909
6 PAEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME 4 0.0851
7 PHYSICAL ABUSE 13 0.0681
8 POSTMORTEM BLOOD DRUG LEVEL ABNORMAL 9 0.0612
9 CYTOTOXIC LESIONS OF CORPUS CALLOSUM 9 0.0608
10 MACULAR DETACHMENT 14 0.0579
11 OBSESSIVE RUMINATION 4 0.0571
12 ANTICHOLINERGIC EFFECT 4 0.0533
13 TERM BIRTH 6 0.0435
14 CHILD NEGLECT 10 0.0415
15 CHANTER SYNDROME 4 0.0400
16 CORONARY ARTERY DISSECTION 32 0.0373
17 VERTEBRAL ARTERY DISSECTION 7 0.0343
18 DECREASED EYE CONTACT 10 0.0329
19 LEGAL PROBLEM 24 0.0326
20 ENVIRONMENTAL EXPOSURE 7 0.0293
21 SUBSTANCE ABUSE 212 0.0260
22 CELLULITIS GANGRENOUS 5 0.0254
23 OPPOSITIONAL DEFIANT DISORDER 10 0.0253
24 MYELOPATHY 48 0.0252
25 CHEMICAL SUBMISSION 6 0.0237
26 AMPHETAMINES POSITIVE 17 0.0227
27 CHOROIDAL EFFUSION 18 0.0224
28 CONGESTIVE HEPATOPATHY 10 0.0223
29 NEUROMUSCULAR BLOCKADE 5 0.0223
30 SUBSTANCE ABUSER 5 0.0220
31 DRUG ABUSE 1773 0.0213
32 VISCERAL CONGESTION 10 0.0196
33 SUBSTANCE USE 30 0.0192
34 NASAL SEPTUM DISORDER 5 0.0188
35 INTERNAL INJURY 12 0.0184
36 SEXUAL ABUSE 8 0.0181
37 HOMICIDE 33 0.0179
38 BLADDER DILATATION 19 0.0174
39 EXPOSURE VIA INGESTION 43 0.0170
40 ACCIDENTAL POISONING 23 0.0168
41 OPIATES POSITIVE 8 0.0167
42 SUBSTANCE USE DISORDER 53 0.0166
43 SOMATIC DELUSION 4 0.0163
44 DRUG DIVERSION 99 0.0160
45 PURPURA FULMINANS 4 0.0157
46 URINE AMPHETAMINE POSITIVE 5 0.0152
47 EXPOSURE TO CONTAMINATED DEVICE 4 0.0152
48 RENAL INFARCT 22 0.0152
49 LOCKED-IN SYNDROME 7 0.0152
50 ADULTERATED PRODUCT 3 0.0150
51 QUADRIPARESIS 24 0.0144
52 INTESTINAL INFARCTION 13 0.0143
53 STAB WOUND 5 0.0141
54 BLOOD ETHANOL INCREASED 3 0.0136
55 BLADDER HYPERTROPHY 6 0.0136
56 SUSPECTED SUICIDE 63 0.0134
57 VICTIM OF SEXUAL ABUSE 7 0.0133
58 TOXICITY TO VARIOUS AGENTS 2241 0.0133
59 POISONING 153 0.0122
60 SUBSTANCE DEPENDENCE 8 0.0119
61 PRODUCT MONITORING ERROR 17 0.0118
62 ANTEROGRADE AMNESIA 7 0.0117
63 ANION GAP 7 0.0110
64 RESPIRATORY ARREST 303 0.0110
65 COMPARTMENT SYNDROME 28 0.0107
66 CHOREOATHETOSIS 7 0.0103
67 FEELING OF RELAXATION 7 0.0102
68 HEPATITIS C VIRUS TEST POSITIVE 6 0.0102
69 COMPLETED SUICIDE 845 0.0101
70 SUSPECTED SUICIDE ATTEMPT 6 0.0101
71 PERSISTENT DEPRESSIVE DISORDER 4 0.0099
72 FOETAL EXPOSURE TIMING UNSPECIFIED 7 0.0097
73 SPHINCTER OF ODDI DYSFUNCTION 4 0.0097
74 DELUSIONAL DISORDER, PERSECUTORY TYPE 4 0.0095
75 BRAIN OEDEMA 119 0.0094
76 CAROTID ARTERY DISSECTION 4 0.0094
77 MITOCHONDRIAL CYTOPATHY 4 0.0091
78 DILATED CARDIOMYOPATHY 9 0.0089
79 CARDIO-RESPIRATORY ARREST 359 0.0086
80 IRREGULAR BREATHING 5 0.0085
81 SPINAL EPIDURAL HAEMATOMA 5 0.0085
82 SEROUS RETINAL DETACHMENT 7 0.0084
83 HEPATORENAL FAILURE 5 0.0083
84 TOXIC LEUKOENCEPHALOPATHY 6 0.0083
85 ALCOHOL ABUSE 22 0.0082
86 RESPIRATORY DEPRESSION 100 0.0082
87 CARDIAC HYPERTROPHY 9 0.0081
88 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 18 0.0080
89 ANTISOCIAL BEHAVIOUR 8 0.0080
90 CENTRAL NERVOUS SYSTEM VASCULITIS 4 0.0078
91 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 20 0.0076
92 ACCIDENTAL DEATH 14 0.0075
93 ALCOHOL POISONING 20 0.0075
94 DRUG USE DISORDER 62 0.0074
95 CLUSTER HEADACHE 10 0.0073
96 ARTERY DISSECTION 3 0.0073
97 MIOSIS 58 0.0072
98 POST-INJECTION DELIRIUM SEDATION SYNDROME 6 0.0070
99 COUNTERFEIT PRODUCT ADMINISTERED 9 0.0069
100 ATTENTION DEFICIT HYPERACTIVITY DISORDER 29 0.0069
101 VICTIM OF HOMICIDE 4 0.0069
102 GUN SHOT WOUND 13 0.0068
103 TRICHOTILLOMANIA 4 0.0068
104 ACUTE LUNG INJURY 8 0.0068
105 NEUROPSYCHOLOGICAL SYMPTOMS 4 0.0066
106 FOETAL DEATH 34 0.0065
107 DRUG SCREEN POSITIVE 51 0.0064
108 SUBRETINAL FLUID 7 0.0064
109 DRUG TOLERANCE INCREASED 5 0.0064
110 BRAIN STEM HAEMORRHAGE 6 0.0063
111 POLYSUBSTANCE ABUSE 4 0.0063
112 ALCOHOL INTERACTION 12 0.0062
113 BLINDNESS CORTICAL 3 0.0061
114 PHAEOCHROMOCYTOMA 4 0.0061
115 THEFT 4 0.0060
116 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 37 0.0060
117 VICTIM OF CHEMICAL SUBMISSION 4 0.0060
118 MYOCARDIAL FIBROSIS 5 0.0060
119 CEREBRAL VENOUS SINUS THROMBOSIS 5 0.0059
120 MULTIPLE DRUG OVERDOSE INTENTIONAL 19 0.0059
121 SEROTONIN SYNDROME 112 0.0058
122 MYOFASCIAL PAIN SYNDROME 4 0.0056
123 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 5 0.0056
124 DRUG DETOXIFICATION 5 0.0056
125 DISSOCIATIVE DISORDER 4 0.0055
126 SLOW RESPONSE TO STIMULI 7 0.0054
127 PUPILLARY REFLEX IMPAIRED 10 0.0054
128 PSYCHOMOTOR SKILLS IMPAIRED 14 0.0053
129 BUNDLE BRANCH BLOCK 5 0.0053
130 DRUG EFFECT VARIABLE 6 0.0053
131 RESPIRATORY ALKALOSIS 8 0.0049
132 CARDIAC ARREST 399 0.0048
133 BRADYPNOEA 13 0.0048
134 STRESS CARDIOMYOPATHY 28 0.0048
135 HYPERKINESIA 10 0.0047
136 MYDRIASIS 60 0.0047
137 SOMATIC SYMPTOM DISORDER 5 0.0046
138 HYPERREFLEXIA 16 0.0046
139 LOGORRHOEA 16 0.0045
140 EXPOSURE TO TOXIC AGENT 14 0.0044
141 MULTIPLE DRUG OVERDOSE 21 0.0042
142 BRAIN DEATH 13 0.0042
143 SEIZURE LIKE PHENOMENA 7 0.0041
144 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 21 0.0041
145 PNEUMONIA STAPHYLOCOCCAL 8 0.0041
146 PULMONARY CONGESTION 53 0.0040
147 HYPOGONADISM 4 0.0040
148 DROWNING 4 0.0040
149 PREMATURE SEPARATION OF PLACENTA 6 0.0039
150 SYSTOLIC DYSFUNCTION 4 0.0038
151 HYPERTHERMIA 29 0.0038
152 ANTICHOLINERGIC SYNDROME 6 0.0038
153 HEPATIC NECROSIS 14 0.0037
154 BRUXISM 20 0.0037
155 SLOW SPEECH 9 0.0037
156 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 5 0.0037
157 HOMICIDAL IDEATION 15 0.0037
158 SKULL FRACTURE 6 0.0037
159 PRODUCT ADMINISTRATION INTERRUPTED 29 0.0037
160 CARDIOGENIC SHOCK 53 0.0037
161 PERICARDIAL HAEMORRHAGE 8 0.0037
162 ISCHAEMIC HEPATITIS 5 0.0036
163 UNRESPONSIVE TO STIMULI 94 0.0036
164 INJECTION SITE ABSCESS 9 0.0036
165 CATAPLEXY 5 0.0035
166 IMPAIRED DRIVING ABILITY 40 0.0035
167 DISTRACTIBILITY 4 0.0035
168 PUPIL FIXED 6 0.0035
169 PULMONARY OEDEMA 154 0.0034
170 OBSTRUCTIVE SLEEP APNOEA SYNDROME 5 0.0034
171 IMPRISONMENT 6 0.0034
172 PSYCHOTIC SYMPTOM 7 0.0034
173 HYPERTHERMIA MALIGNANT 5 0.0034
174 METABOLIC ENCEPHALOPATHY 10 0.0033
175 OBSESSIVE THOUGHTS 6 0.0033
176 ENDOCARDITIS 17 0.0033
177 CLONUS 9 0.0033
178 DRUG ABUSER 19 0.0031
179 INTESTINAL ISCHAEMIA 17 0.0031
180 ASPHYXIA 25 0.0031
181 HYPERAEMIA 6 0.0030
182 POTENTIATING DRUG INTERACTION 10 0.0030
183 LEUKOENCEPHALOPATHY 11 0.0030
184 ACCIDENTAL OVERDOSE 108 0.0029
185 PRODUCT COUNTERFEIT 5 0.0029
186 DRUG SCREEN FALSE POSITIVE 8 0.0029
187 RHABDOMYOLYSIS 120 0.0029
188 POISONING DELIBERATE 27 0.0028
189 HEART INJURY 7 0.0028
190 RESPIRATORY ACIDOSIS 11 0.0028
191 AGGRESSION 140 0.0028
192 EXOPHTHALMOS 6 0.0028
193 PNEUMOMEDIASTINUM 5 0.0028
194 TOXIC ENCEPHALOPATHY 14 0.0028
195 MUTISM 4 0.0028
196 BLOOD LACTIC ACID INCREASED 14 0.0027
197 HYPERCAPNIA 8 0.0027
198 INTERVERTEBRAL DISCITIS 5 0.0026
199 NARCOLEPSY 5 0.0026
200 DRUG TOXICITY 36 0.0026
201 HYPOPNOEA 9 0.0026
202 METHAEMOGLOBINAEMIA 6 0.0026
203 RESPIRATORY RATE DECREASED 8 0.0025
204 METABOLIC ALKALOSIS 4 0.0025
205 PULMONARY ARTERIAL PRESSURE INCREASED 4 0.0025
206 METABOLIC SYNDROME 4 0.0024
207 INTENTIONAL OVERDOSE 156 0.0024
208 VENTRICULAR FIBRILLATION 27 0.0024
209 CYANOSIS 38 0.0024
210 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 5 0.0024
211 PHYSICAL ASSAULT 5 0.0024
212 TIC 13 0.0024
213 SNORING 9 0.0024
214 SUDDEN DEATH 25 0.0024
215 INTENTIONAL DRUG MISUSE 49 0.0023
216 BRAIN HERNIATION 7 0.0023
217 LAZINESS 4 0.0023
218 DEREALISATION 5 0.0023
219 PULMONARY HAEMORRHAGE 18 0.0023
220 VASCULAR PSEUDOANEURYSM 4 0.0023
221 EMOTIONAL POVERTY 4 0.0023
222 DYSPHEMIA 10 0.0023
223 ABNORMAL SLEEP-RELATED EVENT 3 0.0023
224 CONJUNCTIVAL HYPERAEMIA 8 0.0022
225 ANION GAP INCREASED 3 0.0022
226 PRE-EXISTING CONDITION IMPROVED 14 0.0022
227 PRODUCT TAMPERING 4 0.0022
228 FEAR OF DEATH 5 0.0022
229 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 15 0.0022
230 ESSENTIAL HYPERTENSION 4 0.0022
231 OVERDOSE 471 0.0022
232 ACCIDENT 26 0.0022
233 CONGESTIVE CARDIOMYOPATHY 9 0.0022
234 PULSELESS ELECTRICAL ACTIVITY 9 0.0022
235 EUPHORIC MOOD 22 0.0021
236 PARANOIA 37 0.0021
237 TRISMUS 11 0.0021
238 PSYCHOTIC DISORDER 62 0.0021
239 ACIDOSIS 16 0.0021
240 COMA SCALE ABNORMAL 6 0.0021
241 ROAD TRAFFIC ACCIDENT 86 0.0021
242 PSYCHOMOTOR HYPERACTIVITY 34 0.0020
243 NASAL SEPTUM DEVIATION 4 0.0020
244 MULTI-ORGAN DISORDER 4 0.0020
245 ABNORMAL BEHAVIOUR 79 0.0020
246 CORONARY ARTERY THROMBOSIS 4 0.0020
247 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 34 0.0020
248 ENURESIS 8 0.0020
249 TENSION 12 0.0020
250 CHEST INJURY 4 0.0019
251 DEPRESSED LEVEL OF CONSCIOUSNESS 76 0.0019
252 LIVEDO RETICULARIS 4 0.0019
253 INVESTIGATION 6 0.0019
254 AGITATION 140 0.0019
255 TORTICOLLIS 4 0.0019
256 AFFECT LABILITY 18 0.0019
257 BRADYKINESIA 11 0.0019
258 VITREOUS DETACHMENT 4 0.0018
259 SINUS TACHYCARDIA 26 0.0018
260 ASPIRATION 20 0.0018
261 INTENTIONAL PRODUCT MISUSE 159 0.0018
262 COMA 86 0.0018
263 THERAPEUTIC PRODUCT EFFECT VARIABLE 7 0.0018
264 ALTERED STATE OF CONSCIOUSNESS 39 0.0018
265 STREPTOCOCCAL INFECTION 10 0.0018
266 METABOLIC ACIDOSIS 57 0.0018
267 DRUG TOLERANCE 9 0.0018
268 DISSEMINATED INTRAVASCULAR COAGULATION 25 0.0018
269 DISTRIBUTIVE SHOCK 4 0.0018
270 DRUG WITHDRAWAL SYNDROME NEONATAL 26 0.0018
271 READING DISORDER 4 0.0017
272 DRUG LEVEL ABOVE THERAPEUTIC 8 0.0017
273 PRIAPISM 6 0.0017
274 HEPATOMEGALY 17 0.0017
275 SCREAMING 11 0.0017
276 CARDIOMEGALY 21 0.0017
277 SELF-MEDICATION 7 0.0017
278 NYSTAGMUS 9 0.0017
279 SUICIDAL BEHAVIOUR 7 0.0017
280 SUICIDE ATTEMPT 102 0.0017
281 APNOEA 13 0.0017
282 WRONG DOSE 4 0.0017
283 CRANIOCEREBRAL INJURY 5 0.0017
284 DRUG LEVEL INCREASED 27 0.0016
285 ALCOHOL USE 6 0.0016
286 INTRACRANIAL PRESSURE INCREASED 9 0.0016
287 DELUSION 25 0.0016
288 EYE MOVEMENT DISORDER 11 0.0016
289 PERSECUTORY DELUSION 4 0.0016
290 HYPERPARATHYROIDISM SECONDARY 4 0.0016
291 MUSCLE RIGIDITY 19 0.0016
292 EXCORIATION 4 0.0016
293 DRUG INTERACTION 250 0.0016
294 HOSTILITY 4 0.0016
295 WITHDRAWAL SYNDROME 66 0.0016
296 INTENTIONAL SELF-INJURY 31 0.0015
297 SOMNAMBULISM 10 0.0015
298 HALLUCINATION, AUDITORY 24 0.0015
299 ARTERIOSCLEROSIS CORONARY ARTERY 10 0.0015
300 TACHYCARDIA 134 0.0015
301 ENCEPHALOPATHY 37 0.0015
302 ANXIETY DISORDER 5 0.0015
303 ARTERIOSPASM CORONARY 6 0.0015
304 HEPATITIS C 18 0.0015
305 CARDIOMYOPATHY 22 0.0015
306 BLOOD SODIUM INCREASED 4 0.0015
307 COLITIS ISCHAEMIC 10 0.0015
308 SCHIZOPHRENIA 18 0.0015
309 FOETAL GROWTH RESTRICTION 9 0.0015
310 PERIPHERAL ISCHAEMIA 6 0.0015
311 GASTRIC PERFORATION 4 0.0015
312 GASTROINTESTINAL PERFORATION 6 0.0014
313 LUNG CONSOLIDATION 4 0.0014
314 ACUTE PULMONARY OEDEMA 8 0.0014
315 ANTIPSYCHOTIC DRUG LEVEL INCREASED 4 0.0014
316 CONCUSSION 11 0.0014
317 DISTURBANCE IN ATTENTION 76 0.0014
318 ACUTE RESPIRATORY FAILURE 27 0.0014
319 LEFT VENTRICULAR HYPERTROPHY 6 0.0014
320 ALCOHOLISM 6 0.0014
321 TACHYPNOEA 19 0.0014
322 IRRITABILITY 84 0.0014
323 FACIAL BONES FRACTURE 5 0.0014
324 HYPOTHERMIA 14 0.0014
325 ARTERIOSCLEROSIS 13 0.0014
326 HYPERVENTILATION 8 0.0014
327 MAJOR DEPRESSION 10 0.0014
328 HYPERACUSIS 5 0.0013
329 POST-TRAUMATIC STRESS DISORDER 9 0.0013
330 THROAT CLEARING 5 0.0013
331 REBOUND ACID HYPERSECRETION 4 0.0013
332 FACE INJURY 5 0.0013
333 DRUG DEPENDENCE 211 0.0013
334 DELIRIUM 45 0.0013
335 CIRCULATORY COLLAPSE 22 0.0013
336 COORDINATION ABNORMAL 18 0.0013
337 ELECTROENCEPHALOGRAM ABNORMAL 4 0.0013
338 ABDOMINAL ADHESIONS 4 0.0013
339 OBSESSIVE-COMPULSIVE DISORDER 10 0.0012
340 MULTIPLE ORGAN DYSFUNCTION SYNDROME 35 0.0012
341 MATERNAL EXPOSURE DURING BREAST FEEDING 5 0.0012
342 MOUTH HAEMORRHAGE 9 0.0012
343 SEDATION 32 0.0012
344 SPINAL STENOSIS 5 0.0012
345 VENTRICULAR TACHYCARDIA 20 0.0012
346 MOOD ALTERED 33 0.0012
347 LYME DISEASE 4 0.0012
348 BRAIN INJURY 12 0.0012
349 LEFT VENTRICULAR DYSFUNCTION 8 0.0012
350 BRONCHOPNEUMONIA 4 0.0012
351 ELECTROCARDIOGRAM QT PROLONGED 42 0.0012
352 AORTIC ARTERIOSCLEROSIS 3 0.0012
353 FUNCTIONAL GASTROINTESTINAL DISORDER 4 0.0012
354 ENCEPHALITIS 8 0.0012
355 BRAIN FOG 18 0.0011
356 RESTLESSNESS 42 0.0011
357 DYSTONIA 22 0.0011
358 ANIMAL BITE 3 0.0011
359 AREFLEXIA 3 0.0011
360 BEHAVIOUR DISORDER 6 0.0011
361 SEXUAL DYSFUNCTION 13 0.0011
362 PANIC REACTION 8 0.0011
363 BIPOLAR DISORDER 12 0.0011
364 HYDROCEPHALUS 6 0.0011
365 VENTRICULAR ARRHYTHMIA 4 0.0011
366 BUNDLE BRANCH BLOCK RIGHT 5 0.0011
367 NEPHROGENIC ANAEMIA 5 0.0011
368 ACUTE RESPIRATORY DISTRESS SYNDROME 19 0.0011
369 BRADYPHRENIA 7 0.0011
370 PULMONARY ALVEOLAR HAEMORRHAGE 6 0.0011
371 IMPULSIVE BEHAVIOUR 4 0.0011
372 CHRONIC SINUSITIS 4 0.0011
373 DYSKINESIA 43 0.0011
374 TROPONIN INCREASED 8 0.0011
375 PULSE ABSENT 5 0.0011
376 CARDIAC VALVE DISEASE 6 0.0010
377 MANIA 17 0.0010
378 APATHY 15 0.0010
379 TORSADE DE POINTES 8 0.0010
380 ELECTROCARDIOGRAM ABNORMAL 8 0.0010
381 DYSARTHRIA 38 0.0010
382 BLADDER DISORDER 10 0.0010
383 HYPERPHAGIA 4 0.0010
384 VEIN DISORDER 5 0.0010
385 INTRACRANIAL ANEURYSM 4 0.0010
386 PRODUCT PHYSICAL ISSUE 20 0.0010
387 INSURANCE ISSUE 15 0.0010
388 SLUGGISHNESS 10 0.0010
389 INTERVERTEBRAL DISC DEGENERATION 9 0.0010
390 TONGUE DISORDER 7 0.0010
391 AORTIC DISSECTION 4 0.0010
392 PNEUMONIA ASPIRATION 24 0.0010
393 MYOCARDITIS 11 0.0010
394 BLEPHAROSPASM 6 0.0010
395 MULTIPLE INJURIES 6 0.0010
396 PSYCHIATRIC SYMPTOM 7 0.0009
397 SLEEP APNOEA SYNDROME 18 0.0009
398 AORTIC VALVE INCOMPETENCE 4 0.0009
399 SUICIDAL IDEATION 86 0.0009
400 PRODUCT SUBSTITUTION ISSUE 54 0.0009
401 GALACTORRHOEA 6 0.0009
402 SINUS BRADYCARDIA 9 0.0009
403 NEUROLEPTIC MALIGNANT SYNDROME 11 0.0009
404 MULTI-ORGAN FAILURE 16 0.0009
405 ATRIOVENTRICULAR BLOCK FIRST DEGREE 4 0.0009
406 LOSS OF CONSCIOUSNESS 117 0.0009
407 MATERNAL DRUGS AFFECTING FOETUS 7 0.0009
408 PRODUCT FORMULATION ISSUE 6 0.0009
409 CRYING 33 0.0009
410 IMPAIRED QUALITY OF LIFE 13 0.0009
411 SOMNOLENCE 182 0.0009
412 MENTAL STATUS CHANGES 25 0.0009
413 AFFECTIVE DISORDER 7 0.0009
414 TRICUSPID VALVE INCOMPETENCE 7 0.0009
415 PRODUCT AVAILABILITY ISSUE 20 0.0009
416 DRUG EFFECT LESS THAN EXPECTED 13 0.0009
417 HYPERTONIA 5 0.0009
418 FEELING OF DESPAIR 4 0.0009
419 BRONCHIOLITIS 3 0.0009
420 LETHARGY 49 0.0009
421 SKIN TIGHTNESS 4 0.0008
422 MENTAL DISORDER 37 0.0008
423 ENERGY INCREASED 5 0.0008
424 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 8 0.0008
425 FOETAL EXPOSURE DURING PREGNANCY 68 0.0008
426 ANKYLOSING SPONDYLITIS 11 0.0008
427 STILLBIRTH 4 0.0008
428 ENTEROCOCCAL INFECTION 4 0.0008
429 PARKINSONISM 8 0.0008
430 VITAMIN D DECREASED 7 0.0008
431 PRODUCT TASTE ABNORMAL 11 0.0008
432 SCOLIOSIS 5 0.0008
433 HEPATIC STEATOSIS 15 0.0008
434 HYPERNATRAEMIA 4 0.0008
435 SPINAL OSTEOARTHRITIS 7 0.0008
436 CORONARY ARTERY STENOSIS 4 0.0008
437 AUTOIMMUNE THYROIDITIS 3 0.0008
438 HAEMODYNAMIC INSTABILITY 6 0.0008
439 GENERALISED TONIC-CLONIC SEIZURE 13 0.0008
440 MENTAL IMPAIRMENT 19 0.0008
441 MUSCLE TWITCHING 18 0.0008
442 BLINDNESS UNILATERAL 11 0.0008
443 FOOD ALLERGY 6 0.0008
444 DEVELOPMENTAL DELAY 7 0.0008
445 CAESAREAN SECTION 9 0.0008
446 INCOHERENT 5 0.0008
447 EXPOSURE DURING PREGNANCY 48 0.0008
448 SEIZURE 89 0.0008
449 RESTLESS LEGS SYNDROME 14 0.0008
450 BLOOD CREATINE PHOSPHOKINASE INCREASED 22 0.0008
451 MYOCLONUS 9 0.0008
452 OBESITY 12 0.0008
453 FRUSTRATION TOLERANCE DECREASED 6 0.0007
454 ANGER 25 0.0007
455 DEPRESSED MOOD 39 0.0007
456 SHOCK HAEMORRHAGIC 6 0.0007
457 SKIN LACERATION 8 0.0007
458 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 4 0.0007
459 FEELING JITTERY 14 0.0007
460 INTENTIONAL PRODUCT USE ISSUE 64 0.0007
461 ACUTE CORONARY SYNDROME 6 0.0007
462 THERAPEUTIC RESPONSE SHORTENED 24 0.0007
463 ACUTE KIDNEY INJURY 110 0.0007
464 ARRHYTHMIA 34 0.0007
465 HYPERHIDROSIS 92 0.0007
466 EMOTIONAL DISORDER 22 0.0007
467 ACUTE MYOCARDIAL INFARCTION 21 0.0007
468 MYOCARDIAL ISCHAEMIA 8 0.0007
469 HYPOTONIA 7 0.0007
470 BODY TEMPERATURE INCREASED 14 0.0007
471 COGNITIVE DISORDER 32 0.0007
472 FEELING OF BODY TEMPERATURE CHANGE 4 0.0007
473 HYPOXIA 24 0.0007
474 MUSCLE TIGHTNESS 11 0.0007
475 DECREASED INTEREST 4 0.0007
476 CEREBRAL DISORDER 5 0.0007
477 CARDIOTOXICITY 6 0.0007
478 QUALITY OF LIFE DECREASED 9 0.0007
479 MATERNAL EXPOSURE DURING PREGNANCY 59 0.0007
480 AKATHISIA 9 0.0007
481 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 4 0.0007
482 DISSOCIATION 5 0.0007
483 POOR QUALITY SLEEP 14 0.0006
484 SPEECH DISORDER 34 0.0006
485 MEDICATION ERROR 36 0.0006
486 ANKLE FRACTURE 10 0.0006
487 DERMATITIS ATOPIC 34 0.0006
488 LACERATION 6 0.0006
489 SEASONAL ALLERGY 9 0.0006
490 CHRONIC KIDNEY DISEASE 48 0.0006
491 THERAPEUTIC RESPONSE CHANGED 4 0.0006
492 DISORIENTATION 25 0.0006
493 MOOD SWINGS 20 0.0006
494 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
495 HYPERPROLACTINAEMIA 4 0.0006
496 DYSSTASIA 18 0.0006
497 ANXIETY 175 0.0006
498 SHOCK 14 0.0006
499 IMPAIRED WORK ABILITY 13 0.0006
500 LEUKOCYTOSIS 11 0.0006
501 ANEURYSM 3 0.0006
502 HEART RATE DECREASED 21 0.0006
503 SPLENOMEGALY 7 0.0006
504 BREAST MASS 4 0.0006
505 INTERVERTEBRAL DISC PROTRUSION 13 0.0006
506 ECONOMIC PROBLEM 9 0.0006
507 DEPRESSION 135 0.0006
508 ATAXIA 7 0.0006
509 IMPAIRED GASTRIC EMPTYING 8 0.0006
510 BRADYCARDIA 31 0.0006
511 DROOLING 4 0.0006
512 PYELONEPHRITIS 5 0.0006
513 FORMICATION 4 0.0006
514 HALLUCINATION, VISUAL 12 0.0006
515 SLEEP DISORDER 40 0.0006
516 LOSS OF LIBIDO 5 0.0006
517 INJURY 39 0.0006
518 BLOOD POTASSIUM INCREASED 9 0.0006
519 PRODUCT DISPENSING ERROR 12 0.0006
520 PANIC ATTACK 20 0.0005
521 HALLUCINATION 41 0.0005
522 RETINAL DETACHMENT 5 0.0005
523 COAGULOPATHY 9 0.0005
524 FEELING DRUNK 4 0.0005
525 MALNUTRITION 6 0.0005
526 PRODUCT DOSE OMISSION 35 0.0005
527 RESPIRATORY DISORDER 16 0.0005
528 REBOUND EFFECT 6 0.0005
529 OSTEOPENIA 8 0.0005
530 ATELECTASIS 5 0.0005
531 ELECTROLYTE IMBALANCE 6 0.0005
532 VASCULITIS 6 0.0005
533 EJECTION FRACTION DECREASED 8 0.0005
534 PALLOR 14 0.0005
535 NICOTINE DEPENDENCE 4 0.0005
536 PHARYNGEAL SWELLING 5 0.0005
537 COLD SWEAT 9 0.0005
538 CORONARY ARTERY OCCLUSION 7 0.0005
539 MULTIPLE ALLERGIES 4 0.0005
540 BODY TEMPERATURE DECREASED 5 0.0005
541 RESPIRATORY DISTRESS 14 0.0005
542 HUNGER 7 0.0005
543 MOVEMENT DISORDER 16 0.0005
544 NERVOUSNESS 26 0.0005
545 RHINITIS 4 0.0005
546 HYPERTENSION 105 0.0005
547 EMPHYSEMA 5 0.0005
548 ANHEDONIA 13 0.0005
549 MUSCLE SPASTICITY 6 0.0005
550 TREMOR 81 0.0005
551 RIB FRACTURE 10 0.0005
552 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
553 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 4 0.0005
554 TEMPERATURE INTOLERANCE 5 0.0005
555 CYST 6 0.0005
556 MIDDLE INSOMNIA 9 0.0005
557 VENTRICULAR EXTRASYSTOLES 5 0.0005
558 PULMONARY HYPERTENSION 10 0.0005
559 NEPHROLITHIASIS 22 0.0005
560 LIMB INJURY 13 0.0005
561 WEIGHT FLUCTUATION 5 0.0005
562 INFUSION SITE ERYTHEMA 4 0.0005
563 RENAL FAILURE 63 0.0005
564 BALANCE DISORDER 41 0.0005
565 HEAD INJURY 15 0.0005
566 JOINT DISLOCATION 5 0.0005
567 INCREASED APPETITE 9 0.0005
568 JOINT INJURY 10 0.0005
569 ERECTILE DYSFUNCTION 12 0.0005
570 FEELING COLD 13 0.0005
571 MEMORY IMPAIRMENT 64 0.0005
572 INFUSION SITE PAIN 6 0.0005
573 PREMATURE BABY 14 0.0005
574 DECREASED ACTIVITY 5 0.0005
575 MUSCLE STRAIN 4 0.0005
576 CARDIAC MURMUR 4 0.0005
577 PRODUCT PRESCRIBING ISSUE 10 0.0005
578 DEATH 395 0.0005
579 INTENTIONAL DOSE OMISSION 13 0.0005
580 IMMUNE SYSTEM DISORDER 6 0.0005
581 HYPOTENSION 91 0.0005
582 HYPERSOMNIA 13 0.0005
583 APPETITE DISORDER 3 0.0005
584 URINARY RETENTION 15 0.0004
585 PRODUCT ADMINISTRATION ERROR 9 0.0004
586 SURGERY 26 0.0004
587 PSORIATIC ARTHROPATHY 18 0.0004
588 GASTROENTERITIS VIRAL 8 0.0004
589 INSOMNIA 118 0.0004
590 STATUS EPILEPTICUS 5 0.0004
591 END STAGE RENAL DISEASE 8 0.0004
592 MICTURITION URGENCY 5 0.0004
593 SKIN LESION 12 0.0004
594 PALPITATIONS 51 0.0004
595 INCREASED TENDENCY TO BRUISE 4 0.0004
596 PERITONITIS 9 0.0004
597 HEART RATE INCREASED 43 0.0004
598 NIGHTMARE 15 0.0004
599 GRAND MAL CONVULSION 4 0.0004
600 DRUG WITHDRAWAL SYNDROME 38 0.0004
601 BACK DISORDER 7 0.0004
602 MIGRAINE 40 0.0004
603 NERVOUS SYSTEM DISORDER 13 0.0004
604 PULMONARY ARTERIAL HYPERTENSION 6 0.0004
605 PRESCRIBED OVERDOSE 8 0.0004
606 HEMIPARESIS 7 0.0004
607 DIZZINESS POSTURAL 4 0.0004
608 FIBROMYALGIA 10 0.0004
609 THROAT TIGHTNESS 11 0.0004
610 RENAL INJURY 12 0.0004
611 THERAPEUTIC PRODUCT EFFECT DECREASED 18 0.0004
612 SECRETION DISCHARGE 5 0.0004
613 CONFUSIONAL STATE 64 0.0004
614 CARDIOVASCULAR DISORDER 10 0.0004
615 NECK PAIN 22 0.0004
616 EYELID PTOSIS 4 0.0004
617 WOUND 11 0.0004
618 SUBARACHNOID HAEMORRHAGE 4 0.0004
619 MOTOR DYSFUNCTION 4 0.0004
620 INITIAL INSOMNIA 4 0.0004
621 ROTATOR CUFF SYNDROME 5 0.0004
622 LIMB DISCOMFORT 12 0.0004
623 TOOTH LOSS 8 0.0004
624 AMNESIA 25 0.0004
625 RESPIRATORY FAILURE 28 0.0004
626 RETCHING 8 0.0004
627 BACTERIAL INFECTION 7 0.0004
628 BLOOD PRESSURE FLUCTUATION 9 0.0004
629 TUBULOINTERSTITIAL NEPHRITIS 7 0.0004
630 FEELING ABNORMAL 89 0.0004
631 HYPOGLYCAEMIA 18 0.0004
632 DRY MOUTH 30 0.0004
633 BACK INJURY 4 0.0004
634 GINGIVAL BLEEDING 5 0.0004
635 ACUTE HEPATIC FAILURE 5 0.0004
636 TREATMENT NONCOMPLIANCE 20 0.0004
637 CENTRAL NERVOUS SYSTEM LESION 5 0.0004
638 STAPHYLOCOCCAL INFECTION 12 0.0004
639 FOOT DEFORMITY 4 0.0004
640 TRANSAMINASES INCREASED 8 0.0004
641 SKIN DISORDER 12 0.0004
642 OCULAR HYPERAEMIA 17 0.0004
643 PERICARDITIS 6 0.0004
644 UNEVALUABLE EVENT 27 0.0004
645 SKIN INFECTION 4 0.0004
646 GYNAECOMASTIA 11 0.0004
647 ACTIVITIES OF DAILY LIVING IMPAIRED 7 0.0004
648 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 6 0.0004
649 PRODUCT DOSE OMISSION IN ERROR 10 0.0004
650 HYPOPHAGIA 9 0.0004
651 SUBDURAL HAEMATOMA 5 0.0003
652 CARDIAC FAILURE 28 0.0003
653 PARAESTHESIA ORAL 5 0.0003
654 PRODUCT USE ISSUE 65 0.0003
655 FALL 115 0.0003
656 HYPERTHYROIDISM 5 0.0003
657 HYPOAESTHESIA 51 0.0003
658 EAR INFECTION 9 0.0003
659 URINARY INCONTINENCE 10 0.0003
660 CELLULITIS 17 0.0003
661 PRODUCT DOSE OMISSION ISSUE 99 0.0003
662 THIRST 6 0.0003
663 CHOLECYSTITIS 4 0.0003
664 INCORRECT ROUTE OF DRUG ADMINISTRATION 12 0.0003
665 GASTROOESOPHAGEAL REFLUX DISEASE 27 0.0003
666 HYPERLIPIDAEMIA 4 0.0003
667 FEAR 9 0.0003
668 EYE DISORDER 11 0.0003
669 BONE LOSS 5 0.0003
670 APHASIA 10 0.0003
671 LOCALISED INFECTION 8 0.0003
672 FUNGAL INFECTION 11 0.0003
673 BRAIN NEOPLASM 3 0.0003
674 RHINORRHOEA 21 0.0003
675 SPINAL OPERATION 4 0.0003
676 TENDON RUPTURE 4 0.0003
677 MUSCULOSKELETAL CHEST PAIN 5 0.0003
678 PHARYNGITIS 4 0.0003
679 CONDITION AGGRAVATED 98 0.0003
680 EXTRAPYRAMIDAL DISORDER 8 0.0003
681 EMOTIONAL DISTRESS 39 0.0003
682 THINKING ABNORMAL 6 0.0003
683 ILEUS 4 0.0003
684 PSORIASIS 42 0.0003
685 MULTIPLE SCLEROSIS RELAPSE 22 0.0003
686 DRY EYE 16 0.0003
687 ILLNESS 33 0.0003
688 PRODUCT USE COMPLAINT 5 0.0003
689 FOOT FRACTURE 6 0.0003
690 MUSCULOSKELETAL DISORDER 6 0.0003
691 RESPIRATORY TRACT CONGESTION 5 0.0003
692 HEPATOTOXICITY 7 0.0003
693 MULTIPLE SCLEROSIS 15 0.0003
694 ABSCESS 5 0.0003
695 VISION BLURRED 43 0.0003
696 LOWER LIMB FRACTURE 6 0.0003
697 POLLAKIURIA 13 0.0003
698 THERAPY NON-RESPONDER 14 0.0003
699 LIVER FUNCTION TEST ABNORMAL 9 0.0003
700 HIATUS HERNIA 4 0.0003
701 BLOOD PRESSURE INCREASED 47 0.0003
702 CEREBRAL HAEMORRHAGE 11 0.0003
703 HEADACHE 191 0.0003
704 DISABILITY 6 0.0003
705 DEHYDRATION 40 0.0003
706 EYE HAEMORRHAGE 4 0.0003
707 BLOOD UREA INCREASED 5 0.0003
708 CORONARY ARTERY DISEASE 9 0.0003
709 EPILEPSY 9 0.0003
710 FATIGUE 226 0.0003
711 ABNORMAL DREAMS 8 0.0003
712 CARPAL TUNNEL SYNDROME 4 0.0003
713 HEAD DISCOMFORT 5 0.0003
714 CONTUSION 27 0.0003
715 LIVER FUNCTION TEST INCREASED 6 0.0003
716 PARALYSIS 4 0.0003
717 GOUT 5 0.0003
718 ANOSMIA 4 0.0003
719 PELVIC PAIN 5 0.0003
720 PNEUMONIA 89 0.0003
721 HEPATITIS 7 0.0003
722 SINUSITIS 28 0.0003
723 THERAPY CESSATION 14 0.0003
724 ANAPHYLACTIC SHOCK 7 0.0003
725 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 13 0.0003
726 TOOTH DISORDER 6 0.0003
727 MUSCLE SPASMS 49 0.0003
728 BACK PAIN 62 0.0003
729 MOBILITY DECREASED 19 0.0003
730 ASPARTATE AMINOTRANSFERASE INCREASED 14 0.0003
731 VERTIGO 16 0.0003
732 CONVULSION 15 0.0003
733 DRUG ADMINISTRATION ERROR 8 0.0003
734 ALANINE AMINOTRANSFERASE INCREASED 16 0.0003
735 OFF LABEL USE 228 0.0003
736 THYROID DISORDER 4 0.0003
737 WEIGHT INCREASED 58 0.0003
738 TENDONITIS 4 0.0003
739 CHOKING 5 0.0003
740 KIDNEY INFECTION 5 0.0003
741 LYMPHADENOPATHY 9 0.0003
742 PNEUMOTHORAX 4 0.0003
743 BLOOD PRESSURE ABNORMAL 5 0.0003
744 ULCER 4 0.0003
745 PRODUCTIVE COUGH 12 0.0003
746 CYSTITIS 8 0.0003
747 PREMATURE DELIVERY 4 0.0003
748 SEPSIS 28 0.0003
749 SCIATICA 4 0.0003
750 DECREASED APPETITE 58 0.0002
751 PREGNANCY 5 0.0002
752 ADVERSE EVENT 23 0.0002
753 SPINAL FRACTURE 5 0.0002
754 NIGHT SWEATS 8 0.0002
755 TARDIVE DYSKINESIA 7 0.0002
756 DRUG EFFECT INCOMPLETE 9 0.0002
757 HYPERGLYCAEMIA 9 0.0002
758 FEEDING DISORDER 5 0.0002
759 PLEURAL EFFUSION 15 0.0002
760 GAIT DISTURBANCE 47 0.0002
761 CEREBRAL INFARCTION 6 0.0002
762 THERAPEUTIC RESPONSE UNEXPECTED 11 0.0002
763 ABDOMINAL PAIN 57 0.0002
764 RED BLOOD CELL COUNT DECREASED 7 0.0002
765 PRODUCT PREPARATION ERROR 5 0.0002
766 DYSPHAGIA 23 0.0002
767 DRUG INEFFECTIVE 319 0.0002
768 EYE SWELLING 9 0.0002
769 BLOOD ALKALINE PHOSPHATASE INCREASED 6 0.0002
770 DRUG EFFECT DECREASED 13 0.0002
771 TINNITUS 11 0.0002
772 UPPER RESPIRATORY TRACT INFECTION 11 0.0002
773 MUSCULAR WEAKNESS 27 0.0002
774 NAUSEA 188 0.0002
775 TRANSIENT ISCHAEMIC ATTACK 8 0.0002
776 EATING DISORDER 5 0.0002
777 DIZZINESS 117 0.0002
778 URINARY TRACT INFECTION 40 0.0002
779 ADVERSE DRUG REACTION 21 0.0002
780 DYSPEPSIA 23 0.0002
781 HAEMATURIA 8 0.0002
782 WEIGHT DECREASED 65 0.0002
783 INJECTION SITE REACTION 16 0.0002
784 HEPATIC FAILURE 7 0.0002
785 DIPLOPIA 6 0.0002
786 BLOOD CREATININE INCREASED 15 0.0002
787 DEAFNESS 6 0.0002
788 JOINT STIFFNESS 6 0.0002
789 AMENORRHOEA 4 0.0002
790 VOMITING 107 0.0002
791 FLUSHING 23 0.0002
792 INFLUENZA 25 0.0002
793 COVID-19 39 0.0002
794 DYSPHONIA 13 0.0002
795 EXTRA DOSE ADMINISTERED 9 0.0002
796 TOOTHACHE 4 0.0002
797 ABDOMINAL DISCOMFORT 37 0.0002
798 WRONG TECHNIQUE IN DRUG USAGE PROCESS 8 0.0002
799 SKIN DISCOLOURATION 10 0.0002
800 DYSURIA 8 0.0002
801 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 44 0.0002
802 HYPOKALAEMIA 10 0.0002
803 FLUID RETENTION 11 0.0002
804 APHONIA 3 0.0002
805 HEPATIC FUNCTION ABNORMAL 8 0.0002
806 ACCIDENTAL EXPOSURE TO PRODUCT 22 0.0002
807 DISCOMFORT 13 0.0002
808 OSTEOARTHRITIS 9 0.0002
809 BLOOD PRESSURE DECREASED 14 0.0002
810 CHEST PAIN 39 0.0002
811 SYNCOPE 21 0.0002
812 HERPES ZOSTER 12 0.0002
813 POST PROCEDURAL COMPLICATION 4 0.0002
814 PERIPHERAL SWELLING 32 0.0002
815 ASTHENIA 78 0.0002
816 ERUCTATION 4 0.0002
817 INFLUENZA LIKE ILLNESS 17 0.0002
818 DRUG EXPOSURE DURING PREGNANCY 7 0.0002
819 NEURALGIA 5 0.0002
820 HAEMORRHOIDS 4 0.0002
821 NASAL CONGESTION 12 0.0002
822 ABDOMINAL PAIN UPPER 41 0.0002
823 HOT FLUSH 15 0.0002
824 THROMBOSIS 16 0.0002
825 CONTRAINDICATED PRODUCT ADMINISTERED 6 0.0002
826 PRODUCT COMPLAINT 5 0.0002
827 PARAESTHESIA 31 0.0002
828 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 14 0.0002
829 ASTHMA 22 0.0002
830 MUSCULOSKELETAL STIFFNESS 17 0.0002
831 INFLAMMATION 10 0.0002
832 RESPIRATORY TRACT INFECTION 5 0.0002
833 HAEMORRHAGE 20 0.0002
834 DERMATITIS 4 0.0002
835 CEREBROVASCULAR ACCIDENT 32 0.0002
836 PYREXIA 65 0.0002
837 EPISTAXIS 14 0.0002
838 IRRITABLE BOWEL SYNDROME 4 0.0002
839 PRODUCT USE IN UNAPPROVED INDICATION 46 0.0002
840 OEDEMA 10 0.0002
841 PAIN 113 0.0002
842 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
843 WHITE BLOOD CELL COUNT INCREASED 7 0.0002
844 DEPENDENCE 10 0.0002
845 THERAPY INTERRUPTED 13 0.0002
846 RASH 79 0.0002
847 GAMMA-GLUTAMYLTRANSFERASE INCREASED 4 0.0002
848 VIRAL INFECTION 6 0.0002
849 STEVENS-JOHNSON SYNDROME 4 0.0002
850 FEELING HOT 11 0.0002
851 DEMENTIA 5 0.0002
852 GLOSSODYNIA 4 0.0002
853 ARTHRITIS 14 0.0002
854 SKIN EXFOLIATION 15 0.0002
855 CANDIDA INFECTION 3 0.0002
856 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 32 0.0002
857 CHROMATURIA 4 0.0002
858 PRODUCT QUALITY ISSUE 24 0.0002
859 PAIN IN JAW 5 0.0002
860 FLATULENCE 10 0.0002
861 CONSTIPATION 38 0.0002
862 URTICARIA 29 0.0002
863 PAIN IN EXTREMITY 51 0.0002
864 OROPHARYNGEAL PAIN 16 0.0002
865 ECZEMA 9 0.0002
866 DYSPNOEA 97 0.0002
867 OSTEOPOROSIS 7 0.0002
868 INJECTION SITE SWELLING 13 0.0002
869 LABORATORY TEST ABNORMAL 5 0.0002
870 DEEP VEIN THROMBOSIS 11 0.0002
871 HOSPITALISATION 26 0.0002
872 LACRIMATION INCREASED 5 0.0002
873 C-REACTIVE PROTEIN INCREASED 6 0.0002
874 STOMATITIS 10 0.0002
875 LIVER INJURY 4 0.0002
876 ANAPHYLACTIC REACTION 9 0.0002
877 BLOOD GLUCOSE ABNORMAL 3 0.0002
878 INJECTION SITE MASS 6 0.0002
879 ABASIA 4 0.0002
880 FEMUR FRACTURE 5 0.0002
881 COUGH 45 0.0002
882 CARDIAC DISORDER 15 0.0002
883 BLOOD SODIUM DECREASED 3 0.0002
884 ABDOMINAL PAIN LOWER 4 0.0002
885 NEUROPATHY PERIPHERAL 15 0.0002
886 HYPOTHYROIDISM 5 0.0002
887 ARTHRALGIA 65 0.0002
888 GASTROINTESTINAL DISORDER 14 0.0002
889 SKIN ULCER 4 0.0002
890 HAEMATOMA 4 0.0002
891 VISUAL IMPAIRMENT 19 0.0002
892 SKIN IRRITATION 7 0.0002
893 CHOLELITHIASIS 5 0.0002
894 VISUAL ACUITY REDUCED 5 0.0002
895 BRONCHITIS 11 0.0001
896 THERAPEUTIC RESPONSE DECREASED 9 0.0001
897 RASH PRURITIC 8 0.0001
898 PULMONARY EMBOLISM 14 0.0001
899 DISEASE RECURRENCE 7 0.0001
900 INJECTION SITE PAIN 45 0.0001
901 MALAISE 64 0.0001
902 GASTRIC DISORDER 5 0.0001
903 CHILLS 17 0.0001
904 HAEMOPTYSIS 4 0.0001
905 HYPERKALAEMIA 5 0.0001
906 OXYGEN SATURATION DECREASED 8 0.0001
907 NASOPHARYNGITIS 26 0.0001
908 INTERNATIONAL NORMALISED RATIO INCREASED 4 0.0001
909 HYPERSENSITIVITY 26 0.0001
910 LEUKOPENIA 7 0.0001
911 ANGINA PECTORIS 4 0.0001
912 INFECTION 20 0.0001
913 NO ADVERSE EVENT 25 0.0001
914 PRURITUS 53 0.0001
915 WHEEZING 8 0.0001
916 DIARRHOEA 87 0.0001
917 DYSGEUSIA 10 0.0001
918 THROAT IRRITATION 6 0.0001
919 DRUG DOSE OMISSION 22 0.0001
920 INTESTINAL OBSTRUCTION 5 0.0001
921 ALOPECIA 26 0.0001
922 BLOOD CHOLESTEROL INCREASED 6 0.0001
923 BURNING SENSATION 9 0.0001
924 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 7 0.0001
925 DRUG-INDUCED LIVER INJURY 4 0.0001
926 CHEST DISCOMFORT 13 0.0001
927 MYOCARDIAL INFARCTION 22 0.0001
928 ABORTION SPONTANEOUS 5 0.0001
929 ABDOMINAL DISTENSION 13 0.0001
930 EYE PAIN 7 0.0001
931 MYALGIA 21 0.0001
932 OEDEMA PERIPHERAL 15 0.0001
933 SWELLING FACE 8 0.0001
934 EYE IRRITATION 7 0.0001
935 INFUSION RELATED REACTION 8 0.0001
936 AGEUSIA 3 0.0001
937 LIP SWELLING 4 0.0001
938 WHITE BLOOD CELL COUNT DECREASED 13 0.0001
939 INJECTION SITE PRURITUS 8 0.0001
940 RENAL IMPAIRMENT 10 0.0001
941 RENAL FAILURE ACUTE 5 0.0001
942 HYPOACUSIS 5 0.0001
943 JOINT SWELLING 14 0.0001
944 ILL-DEFINED DISORDER 7 0.0001
945 INJECTION SITE ERYTHEMA 14 0.0001
946 SYSTEMIC LUPUS ERYTHEMATOSUS 4 0.0001
947 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 8 0.0001
948 RENAL DISORDER 5 0.0001
949 DIABETES MELLITUS 8 0.0001
950 ANAEMIA 20 0.0001
951 ATRIAL FIBRILLATION 10 0.0001
952 INJECTION SITE BRUISING 8 0.0001
953 BLOOD POTASSIUM DECREASED 3 0.0001
954 TREATMENT FAILURE 8 0.0001
955 INCORRECT DOSE ADMINISTERED 22 0.0001
956 SWELLING 9 0.0001
957 UNDERDOSE 7 0.0001
958 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5 0.0001
959 MUSCULOSKELETAL PAIN 5 0.0001
960 GENERAL PHYSICAL HEALTH DETERIORATION 11 0.0001
961 DEVICE DISLOCATION 4 0.0001
962 PRODUCT STORAGE ERROR 8 0.0001
963 HAEMATOCHEZIA 5 0.0001
964 ANGIOEDEMA 4 0.0001
965 DRUG DOSE OMISSION BY DEVICE 7 0.0001
966 BLISTER 5 0.0001
967 HYPONATRAEMIA 5 0.0001
968 INJECTION SITE HAEMORRHAGE 7 0.0001
969 CATARACT 5 0.0001
970 BLOOD GLUCOSE DECREASED 4 0.0001
971 DRUG INTOLERANCE 8 0.0001
972 DRY SKIN 11 0.0001
973 LUNG DISORDER 4 0.0001
974 RHEUMATOID ARTHRITIS 9 0.0001
975 ACNE 6 0.0001
976 DEVICE EXPULSION 5 0.0001
977 CARDIAC FAILURE CONGESTIVE 6 0.0001
978 BLINDNESS 3 0.0001
979 HEPATIC ENZYME INCREASED 5 0.0001
980 ARTHROPATHY 4 0.0001
981 GASTROINTESTINAL HAEMORRHAGE 6 0.0001
982 PANCYTOPENIA 4 0.0001
983 THROMBOCYTOPENIA 8 0.0001
984 SKIN BURNING SENSATION 5 0.0001
985 BONE PAIN 4 0.0001
986 ERYTHEMA 14 0.0001
987 HAEMOGLOBIN DECREASED 6 0.0001
988 PLATELET COUNT DECREASED 6 0.0001
989 DEVICE ISSUE 5 0.0001
990 BLOOD GLUCOSE INCREASED 10 0.0001
991 MALIGNANT NEOPLASM PROGRESSION 4 0.0000
992 BREAST CANCER 3 0.0000